跳至主要内容
临床试验/NCT03956914
NCT03956914已完成不适用

A 8-weeks, Randomized, Double-blind, Placebo-Controlled, Cross-Over Clinical Trials to Evaluated the Efficacy and Safety of Deep Sea Water on Blood Glucose Level

Chonbuk National University Hospital0 个研究点目标入组 40 人开始时间: 2016年6月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
主要终点
Changes of blood glucose

研究概览

简要总结

This study was conducted to investigate the effects of daily supplementation of deep sea water on improvement of hyperglycemia

详细描述

This study was a 8 weeks, randomized, double-blind, placebo-controlled, cross-over clinical trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Fasting plasma glucose concentration of 100-140 mg/dL or 2h-postprandial plasma glucose concentration of 140 ~199 mg/dL

排除标准

  • Patients with type 1 or type 2 diabetes
  • HbA1c ≥9.0%
  • Weight decreased by more than 10% within past 3 months
  • Have clinically significant acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, hepatic biliary system, kidney and Urinary system, neuropsychiatry, musculoskeletal, inflammatory and hematologic malignancies, gastrointestinal disorders, etc.
  • Hypoglycemic agent, obesity medicine, lipid lowering agent within past 6 months or functional food within past 2 month
  • Subjects who have taken corticosteroid within past 1 months
  • History of alcohol or substance abuse
  • Participation in any other clinical trials within past 2 months
  • Laboratory test by show the following results
  • Serum AST (aspartate aminotransferase) or ALT (alanine aminotransferase) > 2 times the upper limit of normal range
  • Serum Creatinine > 2.0 mg/dl
  • Pregnancy or breast feeding
  • If a woman of childbearing doesn't accept the implementation of appropriate contraception
  • Principal Investigator judged inappropriate for participation in study because of Laboratory test result, etc

结局指标

主要结局

Changes of blood glucose

时间窗: Baseline, 8 weeks

Concentration of fasting and postprandial glucose during OGTT (oral glucose tolerance test) were assessed before and after the intervention

次要结局

  • Weight(Baseline, 8 weeks)
  • Changes of blood insulin(Baseline, 8 weeks)
  • Waist circumference(Baseline, 8 weeks)
  • C-pepetide(Baseline, 8 weeks)
  • Homeostatic model assessment - insulin resistance (HOMA-IR)(Baseline, 8 weeks)
  • LDL-cholesterol(Baseline, 8 weeks)
  • HbA1c(Baseline, 8 weeks)
  • Triglyceride(Baseline, 8 weeks)
  • HDL-cholesterol(Baseline, 8 weeks)
  • BMI(Baseline, 8 weeks)
  • Body fat mass(Baseline, 8 weeks)
  • Percent of body fat mass(Baseline, 8 weeks)
  • Total cholesterol(Baseline, 8 weeks)
  • Waist-hip ratio (WHR)(Baseline, 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soo-Wan Chae

Principal Investigator

Chonbuk National University Hospital

相似试验